U.S. Stocks Rally on Hopes for Coronavirus Drug: Markets Wrap
- Megacap tech companies rally as Alphabet sales top estimates
- Federal Reserve policy makers see medium-term risks on growth
This article is for subscribers only.
U.S. stocks rallied to a seven-week high on better-than-estimated revenue for Google’s parent company and hopes for a coronavirus treatment. Oil surged.
The S&P 500 Index gained 2.7% in a broad advance, with four stocks up for every one that fell after Gilead Sciences Inc. said its experimental drug helped Covid-19 patients recover faster. The Nasdaq Composite Index rose to within 1% of erasing losses for the year, led by Alphabet Inc. after it reported an ad-sales slowdown that wasn’t as bad as expected.